Legal Library: Cases and Proceedings

WARNING: Don't be fooled by callers asking for money who pretend to be employed by or on behalf of the Federal Trade Commission or helping to refund money recovered by the Commission. When the Commission seeks refund for consumers through its law enforcement efforts, it does not ask consumers to pay anything. It also does not authorize anyone else to collect such payments. If someone asks you to pay a fee to receive money, do not pay. Please let us know about it by filing a complaint at www.ftc.gov/complaint, or call Harold Kirtz, an FTC attorney, directly at 404-656-1357 if this concerns the alleged return of money from the Resort Solution Trust scam.

Akorn Enterprises, Inc. and Hi-Tech Pharmacal, Inc. agreed to sell the rights and assets to three generic prescription eye medications and two generic topical anesthetics to Watson Laboratories, Inc., to settle FTC charges that Akorn’s proposed $640 million acquisition of Hi-Tech would be anticompetitive and lead to higher prices for consumers. The proposed order requires the parties to sell either Akorn’s or Hi-Tech’s rights and assets to each of the five drug products to Watson, and requires Akorn to assign Watson its contract for making branded and generic EMLA cream within 10 days after the deal is consummated. In addition, the companies must maintain the drugs to be sold as viable, marketable, and competitive pending their divestiture, and must allow the FTC to appoint a monitor to ensure that the companies comply with the order’s requirements.